Alteration of the glycolipid binding specificity of the pig edema toxin from globotetraosyl to globotriaosyl ceramide alters in vivo tissue targetting and results in a verotoxin 1-like disease in pigs.

PubWeight™: 1.07‹?› | Rank: Top 10%

🔗 View Article (PMC 2191045)

Published in J Exp Med on June 01, 1993

Authors

B Boyd1, G Tyrrell, M Maloney, C Gyles, J Brunton, C Lingwood

Author Affiliations

1: Department of Microbiology, Hospital for Sick Children, Toronto, Ontario, Canada.

Articles citing this

Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections. Clin Microbiol Rev (1998) 8.74

Cattle lack vascular receptors for Escherichia coli O157:H7 Shiga toxins. Proc Natl Acad Sci U S A (2000) 1.38

Clonal relatedness of Shiga-like toxin-producing Escherichia coli O101 strains of human and porcine origin. J Clin Microbiol (1995) 1.34

Escherichia coli O157:H7 causes more-severe systemic disease in suckling piglets than in colostrum-deprived neonatal piglets. Infect Immun (2000) 1.13

Stx2-specific human monoclonal antibodies protect mice against lethal infection with Escherichia coli expressing Stx2 variants. Infect Immun (2003) 1.12

Interaction of verotoxin 2e with pig intestine. Infect Immun (1996) 1.08

Evidence that verotoxins (Shiga-like toxins) from Escherichia coli bind to P blood group antigens of human erythrocytes in vitro. Infect Immun (1994) 1.04

The bacterial colicin active against tumor cells in vitro and in vivo is verotoxin 1. Proc Natl Acad Sci U S A (1995) 0.98

CD19 has a potential CD77 (globotriaosyl ceramide)-binding site with sequence similarity to verotoxin B-subunits: implications of molecular mimicry for B cell adhesion and enterohemorrhagic Escherichia coli pathogenesis. J Exp Med (1994) 0.97

Identification of a novel streptococcal adhesin P (SadP) protein recognizing galactosyl-α1-4-galactose-containing glycoconjugates: convergent evolution of bacterial pathogens to binding of the same host receptor. J Biol Chem (2011) 0.92

Shiga toxin binding to isolated porcine tissues and peripheral blood leukocytes. Infect Immun (2004) 0.84

Binding of shiga toxin 2e to porcine erythrocytes in vivo and in vitro. Infect Immun (2003) 0.82

Localization of potential binding sites for the edema disease verotoxin (VT2e) in pigs. Can J Vet Res (1998) 0.81

Sodium deoxycholate facilitates systemic absorption of verotoxin 2e from pig intestine. Infect Immun (1995) 0.80

Globotriaosyl ceramide modulates interferon-alpha-induced growth inhibition and CD19 expression in Burkitt's lymphoma cells. Glycoconj J (1999) 0.80

Therapeutic use of a receptor mimic probiotic reduces intestinal Shiga toxin levels in a piglet model of hemolytic uremic syndrome. BMC Res Notes (2014) 0.77

A Topographical Atlas of Shiga Toxin 2e Receptor Distribution in the Tissues of Weaned Piglets. Toxins (Basel) (2016) 0.75

Articles cited by this

Hemorrhagic colitis associated with a rare Escherichia coli serotype. N Engl J Med (1983) 25.72

The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. J Infect Dis (1985) 16.43

Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro. J Biol Chem (1987) 3.71

Globotriosyl ceramide is specifically recognized by the Escherichia coli verocytotoxin 2. Biochem Biophys Res Commun (1988) 2.65

The histopathology of the hemolytic uremic syndrome associated with verocytotoxin-producing Escherichia coli infections. Hum Pathol (1988) 2.51

Retrograde transport of endocytosed Shiga toxin to the endoplasmic reticulum. Nature (1992) 2.49

Crystal structure of the cell-binding B oligomer of verotoxin-1 from E. coli. Nature (1992) 2.32

Comparison of the glycolipid receptor specificities of Shiga-like toxin type II and Shiga-like toxin type II variants. Infect Immun (1990) 2.32

Experimental verocytotoxemia in rabbits. Infect Immun (1992) 1.94

Globotetraosylceramide is recognized by the pig edema disease toxin. J Biol Chem (1989) 1.88

Verotoxin receptor glycolipid in human renal tissue. Nephron (1989) 1.88

Alteration of the carbohydrate binding specificity of verotoxins from Gal alpha 1-4Gal to GalNAc beta 1-3Gal alpha 1-4Gal and vice versa by site-directed mutagenesis of the binding subunit. Proc Natl Acad Sci U S A (1992) 1.43

Characterization of Shiga-like toxin I B subunit purified from overproducing clones of the SLT-I B cistron. Biochem J (1990) 1.30

Induction of verotoxin sensitivity in receptor-deficient cell lines using the receptor glycolipid globotriosylceramide. Proc Natl Acad Sci U S A (1990) 1.27

Verotoxin glycolipid receptors determine the localization of microangiopathic process in rabbits given verotoxin-1. J Lab Clin Med (1992) 1.22

Characterization and regulation of alpha-interferon receptor expression in interferon-sensitive and -resistant human lymphoblastoid cells. J Biol Chem (1984) 1.10

Susceptibility to verotoxin as a function of the cell cycle. J Cell Physiol (1992) 0.91

Assessment of microsphere technique for measurement of capillary blood flow in random skin flaps in pigs. Plast Reconstr Surg (1984) 0.85

Modification of the glycolipid-binding specificity of vero cytotoxin by polymyxin B and other cyclic amphipathic peptides. Infect Immun (1990) 0.85

Articles by these authors

The enterotoxin plasmids of Escherichia coli. J Infect Dis (1974) 9.10

emm typing and validation of provisional M types for group A streptococci. Emerg Infect Dis (1999) 3.12

Sequence heterogeneity of the eae gene and detection of verotoxin-producing Escherichia coli using serotype-specific primers. Epidemiol Infect (1994) 2.70

Globotriosyl ceramide is specifically recognized by the Escherichia coli verocytotoxin 2. Biochem Biophys Res Commun (1988) 2.65

Nucleotide sequence and promoter mapping of the Escherichia coli Shiga-like toxin operon of bacteriophage H-19B. J Bacteriol (1987) 2.65

Biochemical characteristics of Haemophilus influenzae in relationship to source of isolation and antibiotic resistance. J Clin Microbiol (1978) 2.60

Cloning and nucleotide sequence of the eae gene homologue from enterohemorrhagic Escherichia coli serotype O157:H7. FEMS Microbiol Lett (1992) 2.58

Globotetraosylceramide is recognized by the pig edema disease toxin. J Biol Chem (1989) 1.88

Development of verotoxin 2- and verotoxin 2 variant (VT2v)-specific oligonucleotide probes on the basis of the nucleotide sequence of the B cistron of VT2v from Escherichia coli E32511 and B2F1. J Clin Microbiol (1991) 1.88

Verotoxin receptor glycolipid in human renal tissue. Nephron (1989) 1.88

Expression and characterization of the eaeA gene product of Escherichia coli serotype O157:H7. Infect Immun (1993) 1.84

Determination of the vasodilator UK33274 by high-performance liquid chromatography using fluorescence detection. J Chromatogr (1980) 1.79

Outer membranes are competitive inhibitors of Escherichia coli O157:H7 adherence to epithelial cells. Infect Immun (1991) 1.77

Determination of antimicrobial susceptibilities of Canadian isolates of Haemophilus influenzae and characterization of their beta-lactamases. Canadian Haemophilus Study Group. Antimicrob Agents Chemother (1994) 1.69

Evolution of enterohemorrhagic Escherichia coli hemolysin plasmids and the locus for enterocyte effacement in shiga toxin-producing E. coli. Infect Immun (1998) 1.68

Comparison of Helicobacter pylori and attaching-effacing Escherichia coli adhesion to eukaryotic cells. Infect Immun (1993) 1.67

The right to effective education. Behav Anal (1991) 1.62

A multicenter randomized double-blind placebo-controlled trial of adjunctive corticosteroids in the treatment of Pneumocystis carinii pneumonia complicating the acquired immune deficiency syndrome. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 1.61

Targeting of Shiga toxin B-subunit to retrograde transport route in association with detergent-resistant membranes. Mol Biol Cell (2001) 1.57

Hospital-acquired invasive group a streptococcal infections in Ontario, Canada, 1992-2000. Clin Infect Dis (2005) 1.54

Multiple determinants of verotoxin-producing Escherichia coli O157:H7 attachment-effacement. Infect Immun (1993) 1.53

Effect of bicuculline on thalamic activity: a direct blockade of IAHP in reticularis neurons. J Neurophysiol (1998) 1.47

Sensitive receptor-specified enzyme-linked immunosorbent assay for Escherichia coli verocytotoxin. J Clin Microbiol (1989) 1.41

Molecular epidemiology of beta-lactamase-specifying plasmids of Haemophilus ducreyi. Antimicrob Agents Chemother (1982) 1.41

Positive and negative symptoms in schizophrenia. A critical reappraisal. Arch Gen Psychiatry (1990) 1.35

Characterization of Shiga-like toxin I B subunit purified from overproducing clones of the SLT-I B cistron. Biochem J (1990) 1.30

Enzyme-linked immunosorbent assay for detection of immunoglobulin G antibodies to Escherichia coli Vero cytotoxin 1. J Clin Microbiol (1994) 1.28

Molecular nature of a plasmid specifying beta-lactamase production in Haemophilus ducreyi. J Bacteriol (1981) 1.24

Verotoxin glycolipid receptors determine the localization of microangiopathic process in rabbits given verotoxin-1. J Lab Clin Med (1992) 1.22

Molecular epidemiology of antibiotic resistance plasmids of Haemophilus species and Neisseria gonorrhoeae. Rev Infect Dis (1986) 1.18

A blinded comparison of three laboratory protocols for the identification of patients colonized with methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol (2001) 1.13

pH-independent retrograde targeting of glycolipids to the Golgi complex. Am J Physiol (1998) 1.13

Enterotoxigenic Escherichia coli in central Canada. J Clin Microbiol (1980) 1.11

Infectious agents in acute respiratory disease in horses in Ontario. J Vet Diagn Invest (1997) 1.11

Intranodal immunization with tumor lysate-pulsed dendritic cells enhances protective antitumor immunity. Cancer Res (2001) 1.10

Ileal perforation due to cytomegaloviral enteritis. Can J Surg (1986) 1.08

Rubella screening and follow-up immunization in Vermont. Am J Public Health (1979) 1.06

The genetic basis of the spread of beta-lactamase synthesis among plasmid-carrying bacteria. Philos Trans R Soc Lond B Biol Sci (1980) 1.05

Comorbidity of substance abuse and schizophrenia: the role of pre-morbid adjustment. Psychol Med (1992) 1.05

"Spot 14" protein functions at the pretranslational level in the regulation of hepatic metabolism by thyroid hormone and glucose. J Biol Chem (1997) 1.04

Intracytoplasmic sperm injection: achievement of high pregnancy rates in couples with severe male factor infertility is dependent primarily upon female and not male factors. Fertil Steril (1995) 1.03

Brief heat shock treatment induces a long-lasting alteration in the glycolipid receptor binding specificity and growth rate of Haemophilus influenzae. Infect Immun (1997) 0.98

Glycosphingolipid depletion in fabry disease lymphoblasts with potent inhibitors of glucosylceramide synthase. Kidney Int (2000) 0.97

Effects of errors in a multicenter medical study: preventing misinterpreted data. J Psychiatr Res (1995) 0.96

Diarrhea among infants and young children in Canada: a longitudinal study in three northern communities. J Infect Dis (1983) 0.96

Factors associated with noncompliance of patients taking antihypertensive medications. Hosp Pharm (1995) 0.96

Origin of small beta-lactamase-specifying plasmids in Haemophilus species and Neisseria gonorrhoeae. J Bacteriol (1986) 0.95

Application of multiplex PCR for detection of non-O157 verocytotoxin-producing Escherichia coli in bloody stools: identification of serogroups O26 and O111. J Clin Microbiol (1998) 0.95

Verotoxin induces apoptosis and the complete, rapid, long-term elimination of human astrocytoma xenografts in nude mice. Oncol Res (1999) 0.95

Lack of efficacy of oral bacitracin plus doxycycline for the eradication of stool colonization with vancomycin-resistant Enterococcus faecium. Clin Infect Dis (1999) 0.95

Investigation of a multiyear multiple critical care unit outbreak due to relatively drug-sensitive Acinetobacter baumannii: risk factors and attributable mortality. J Infect Dis (1996) 0.95

Neutralization receptor-based immunoassay for detection of neutralizing antibodies to Escherichia coli verocytotoxin 1. J Clin Microbiol (1990) 0.94

The ATPase domain of hsp70 possesses a unique binding specificity for 3'-sulfogalactolipids. J Biol Chem (2001) 0.94

Vancomycin-resistant enterococci on a renal ward in an Ontario hospital. Can Commun Dis Rep (1996) 0.93

Are immunoassays for digoxin reliable? Clin Biochem (1984) 0.92

The air crescent sign caused by Staphylococcus aureus lung infection in a neutropenic patient with leukemia. Ann Intern Med (1992) 0.92

Use of the QuantiFERON-TB Gold test to confirm latent tuberculosis infection in a Canadian tuberculosis clinic. Int J Tuberc Lung Dis (2009) 0.92

Tissue distribution of sulfolipids in the rat. Restricted location of sulfatoxygalactosylacylalkylglycerol. Can J Biochem (1981) 0.92

Induction of STEAP4 correlates with 1,25-dihydroxyvitamin D3 stimulation of adipogenesis in mesenchymal progenitor cells derived from human adipose tissue. J Cell Physiol (2013) 0.91

Application of a DNA hybridization-hydrophobic-grid membrane filter method for detection and isolation of verotoxigenic escherichia coli. Appl Environ Microbiol (1999) 0.91

Delay of adequate empiric antibiotic therapy is associated with increased mortality among solid-organ transplant patients. Am J Transplant (2009) 0.89

Attaching and effacing Escherichia coli isolated from dogs in Brazil: characteristics and serotypic relationship to human enteropathogenic E. coli (EPEC). Vet Microbiol (2004) 0.89

Comparison between short-term renal haemodynamic effects of propranolol and nadolol in essential hypertension: a cross-over study. Clin Sci (Lond) (1984) 0.88

Immunity to Escherichia coli in pigs: anti-enterotoxins in colostrum and serum from vaccinated and non-vaccinated sows. Can J Comp Med (1971) 0.88

Local hepatic tuberculosis, the cause of a painful hepatic mass: case report and review of the literature. Can J Surg (1986) 0.88

A prospective audit of wound infection rates after caesarean section in five West Yorkshire hospitals. J Hosp Infect (1996) 0.87

Gas diffusion across collateral channels. J Appl Physiol (1972) 0.86

3'Sulfogalactolipid binding specifically inhibits Hsp70 ATPase activity in vitro. Biochemistry (2003) 0.86

Possible involvement of noradrenaline in the response of rat kidney cortex slices to angiotensin [proceedings]. J Physiol (1978) 0.86

Detection of toxin genes in Escherichia coli isolated from normal dogs and dogs with diarrhea. Can J Vet Res (1995) 0.85

Modification of the glycolipid-binding specificity of vero cytotoxin by polymyxin B and other cyclic amphipathic peptides. Infect Immun (1990) 0.85

Cross-Canada spread of methicillin-resistant Staphylococcus aureus via transplant organs. Clin Infect Dis (1999) 0.85

The aglycone of sulfogalactolipids can alter the sulfate ester substitution position required for hsc70 recognition. Carbohydr Res (2001) 0.85

Old age and its behavioral manifestations: a study on two species of macaque. Folia Primatol (Basel) (1984) 0.85

T1 and T2 relaxation times in schizophrenia as measured with magnetic resonance imaging. Schizophr Res (1991) 0.84

Localization of sulfatoxygalactosylacylalkylglycerol at the surface of rat testicular germinal cells by immunocytochemical techniques: pH dependence of a nonimmunological reaction between immunoglobulin and germinal cells. J Cell Biol (1981) 0.84

Deficiency in the regulation of testicular galactolipid sulphotransferase in rats carrying the growth-and-reproduction-complex (grc) gene. Biochem J (1985) 0.84

Spot 14 protein-protein interactions: evidence for both homo- and heterodimer formation in vivo. Endocrinology (1997) 0.84

Comparative cytotoxicity of purified Shiga-like toxin-IIe on porcine and bovine aortic endothelial and human colonic adenocarcinoma cells. J Med Microbiol (1996) 0.84

Chemical composition, gross structure, and organization of transformation-sensitive glycoproteins. Ann N Y Acad Sci (1978) 0.83

Evaluation of teleradiology in Scotland. J Telemed Telecare (1996) 0.83

Crystallization and preliminary X-ray crystallographic analysis of verotoxin-1 B-subunit. J Mol Biol (1991) 0.83

Escherichia coli verotoxin binding to human paediatric glomerular mesangial cells. Pediatr Nephrol (1995) 0.82

Expression and sulfogalactolipid binding specificity of the recombinant testis-specific cognate heat shock protein 70. Glycoconj J (1997) 0.82

Murine antibody responses to the verotoxin 1 B subunit: demonstration of major histocompatibility complex dependence and an immunodominant epitope involving phenylalanine 30. Infect Immun (1997) 0.82

Assignment of the "spot 14" gene (THRSP) to human chromosome band 11q13.5 by in situ hybridization. Cytogenet Cell Genet (1997) 0.81

Prevalence of Staphylococcus aureus and methicillin-resistant S. aureus (MRSA) in food samples associated with foodborne illness in Alberta, Canada from 2007 to 2010. Food Microbiol (2012) 0.81

Pilot study of growth hormone administration during the refeeding of malnourished anorexia nervosa patients. J Child Adolesc Psychopharmacol (2000) 0.81

A case-control study of verocytotoxigenic Escherichia coli infection in cats with diarrhea. Can J Vet Res (1998) 0.80

Synthesis and use of galactolipid sulfotransferase substrate-analogue affinity probes: possible localization of the testicular enzyme. Biochem Cell Biol (1986) 0.80

Modulation of testicular galactolipid sulfotransferase activity in vitro by ATP. Biochim Biophys Acta (1987) 0.80

Verocytotoxigenic Escherichia coli infection in dairy farm families. Can Commun Dis Rep (1998) 0.79

Therapeutics used to alleviate peptic ulcers inhibit H. pylori receptor binding in vitro. Zentralbl Bakteriol (1993) 0.79

Increased globotriaosylceramide on plasma membranes of synchronized familial dysautonomia cells. Verotoxin binding studies. J Mol Neurosci (1994) 0.79

Peripheral airway obstruction and particulate deposition in the lung. Arch Intern Med (1973) 0.78

In vivo transfer of an Escherichia coli enterotoxin plasmid possessing genes for drug resistance. Am J Vet Res (1978) 0.78